and Adult Respiratory Distress Syndrome. A fistula between the bronchus of the right middle lobe and the pulmonary artery due to an invasive aspergillosis was the cause of the lethal bleeding (Plate 1). In addition, an invasive aspergillosis infection of the brain was demonstrated by a local lesion in the right occipital lobe, with involvement of the vessels with a diameter of 2.5 cm.
Discussion
A change towards more aggressive treatment in CF patients has lengthened their life-expectancy and many patients survive into adolescence. In accordance, lung transplantation has become one of the tools in the therapeutic regimen. However, shortage of suitable donor organs requires careful selection of recipients who would benefit from transplantation. Therefore, individual prognosis, quality of life and degree of disability must be evaluated both for surgical and post-operative management (1,2). Invasive disseminated aspergillosis is one of the most devastating opportunistic infections, which usually occurs in immunocompromised patients (3) . Furthermore, diabetes mellitus -which occurs in about 15% of CF patients ~ predisposes to many infections. Aspergillus infections occur in 2-8% of patients with solid organ transplants (4). However, in lung transplantation patients, aspergillosis is often under-diagnosed since Plate 1 Bronchial structure (B) and adjacent pulmonary artery (PA). Accumulation of A. fumigatus on the bronchial mucosal surface and invasion of the bronchial wall causing a fistula (*) between the bronchus of the right middle lobe and pulmonary artery.
the underlying disease itself may be associated with similar symptoms (4,5). For those with disseminated disease and invasion of the central nervous system, outcome has mostly been fatal (4-7). Cerebral invasion by haematogenous dissemination may result in a variety of neurological signs. Cerebral aspergillosis should be strongly suspected in patients who develop pulmonary infiltrates and focal neurological signs, especially if they have received high dose steroids (6,7). Boon et al. (6) found invasive cerebral aspergillosis in 20% (n=9) of the patients who died after liver transplantation.
In only two of these cases, the diagnosis was established before death. A biopsy specimen of an unusual rash may be the only means of establishing an early diagnosis of a disseminated fungal infection and is worthy of consideration. Therefore, the dermatological manifestations of systemic aspergillosis should not be overlooked.
The case described above illustrates a disseminated manifestation of infection with A. jiimigatus after bilateral lung transplantation. Predisposing factors -such as prolonged survival through intensive supportive treatment, rejection episodes with, as a consequence, an increase of immunosuppression, which predispose for infections, diabetes mellitus, and high dose corticosteroids -may have given the organism an opportunity to disseminate more widely (2, 8) . Before transplantation, colonization with A. fumigatus in the lung alone was documented in this patient. Seven days after transplantation, cultures of wound, cerumen and drains, as well, became positive for A. jiimigatus.
Therefore, we suggest that colonization before operation predisposes for invasive aspergillosis and treatment should be considered.
Despite antifungal treatment, the CF patient described died due to invasion of A. jiimigatus. With regard to aspergillosis, the prognosis of survival after lung transplantation in CF depends on (preoperative) clinical presentation and pre-operative screening (using well-defined criteria) for colonization of the entire respiratory tract, with high attention for the diverse manifestations of disseminated aspergillosis.
